Airborne moulds are ubiquitous and have evolved to exploit the man-made spatial ecosystems of our built environment. In the enclosed environment, especially where there is dampness and condensation, they manip ulate the microclimates and ecological niches of our buildings and feed on a variety of substrates. Over the last century, the management of mould problems in buildings has largely relied on a misunderstanding and misdiagnosis of the biology, ecology and physiology of the causal organisms. Mould growth in buildings may affect the health of occupants in many ways and may contribute to the sick-building syndrome as well as aller gy and other environmental health problems. The conse quences of occupational exposure to moulds are gaining prominence because of demands for better working con ditions. There is a need to look after and hopefully improve the health, comfort and productivity of a build ing's occupants.
Gravesen S., Nielsen PA, Iversen R., Nielsen KF: Microfungal contamination of damp buildings - Examples of constructions and risk materials. Environ Health Perspect1999 ; 107(suppl 3):505-508.
Centers for Disease Control and Prevention : Update: Pulmonary hemorrhage/hemosiderosis among infants - Cleveland, Ohio, 1993-1996. MMWR Morb Mortal Wkly Rep1997; 46:33-35.
5.
Malkin R., Martinez K., Marinkovich V., Wilcox T., Wall D., Biagini R.: The relationship between symptoms and IgG and IgE antibodies in an office environment. Environ Res1998 ;76:85-93.
6.
Strachan DP, Flannigan B., McCabe EM, McGarry F: Quantification of airborne moulds in the homes of children with and without wheeze. Thorax1990;45:382-387.
7.
Dales RE, Burned R., Zwanenburg H.: Adverse health effects among adults exposed to home dampness and molds . Am Rev Respir Dis1991;143:505-509.
8.
Spengler J., Neas L., Nakai S., Dockery D., Speizer F., Ware J., Raizenne M.: Respiratory symptoms and housing characteristics. Indoor Air1994;4:72-84.
9.
Etzel RA, Montaña E., Sorenson WG, Kullman GJ, Allan TM, Dearborn DG: Acute pulmonary hemorrhage in infants associated with exposure to Stachybotrys atra and other fungi. Arch Pediatr Adolesc Med1998;152:757-762.
10.
Koskinen O. , Husman T., Meklin T., Nevalainen A.: The relationship between moisture or mould observations in houses and the state of health of their occupants. Eur Respir J1999;14:1363-1367.
11.
Lawton MD, Dales RE, White J.: The influence of house characteristics in a Canadian community on microbiological contamination. Indoor Air1998;8:2-11.
12.
Haverinen U. , Husman T., Pekkanen J., Vahteristo M., Moschandreas D., Nevalainen A.: Characteristics of moisture damage in houses and their association with self-reported symptoms of the occupants. Indoor Built Environ2001 ; 10:83-94.
13.
doPico GA: Report on diseases. Am J Indust Med1986;10:261-265.
14.
Parker JE, Petsonk EL, Weber SL: Hypersensitivity pneumonitis and organic dust toxic syndrome. Immunol Allergy Clin North Am1992; 12:279-290.
15.
SNB: Organic Dust in Agriculture: General Recommendations of the Swedish National Board of Occupational Safety and Health on Organic Dust in Agriculture. Adopted 15th June 1994. AFS 1994, p 11.
16.
Adhikari A., Sen MM, Gupta-Bhattacharya S., Chandra S.: Studies on airborne fungal spores from two indoor cowsheds of sub-urban and rural areas of West Bengal, India. Indoor Built Environ1999;8:221-229.
Institute of Medicine: Indoor allergens; in Pope AM, Patterson R, Burge HA (eds): Assessing and Controlling Adverse Health Effects. Committee on Health Effects and Indoor Allergens, Division of Health Promotion and Disease Prevention, Institute of Medicine. Washington, National Academy Press, 1993.
19.
Singh J.: Health, comfort and productivity in the indoor environment. Indoor Built Environ1996;5:22-34.
20.
Singh J.: Impact of indoor air pollution on health, comfort and productivity of the occupants. Aerobiologia1996;12:121-127.
21.
Singh J.: Sick building syndrome. Facilities Management Health Safety , November 1999, pp 12-15.
22.
Singh J.: Biological contaminants in the built environment and their health implications. Building ResInform1993;21:216-224.
23.
Singh J.: Sick building syndrome. Occup Health Hyg Health Safety December 1999, pp 14-16.
24.
Gots RE: How to monitor and prevent indoor environmental problems; in O'Reilly JT, Hagan P, Gots R, Hedge A (eds): Keeping Buildings Healthy. New York, Wiley & Sons, 1998 .
25.
Finnegan MJ , Pickering Cac, Burge PS: The sick building syndrome: Prevalence studies . Br Med J1984;289:1573-1575.
26.
Singh J., Walker B.: Allergy Problem in Buildings. Lancaster, Quay Publishing, 1994.
27.
Pasanen P., Pasanen AL, Jantunen M.: Water condensation promotes fungal growth in ventilation ducts. Indoor Air1993;3:106-112.
28.
Singh J.: Building Mycology, Management of Health and Decay in Buildings. London, Spon, 1994.
29.
Curtis L., Ross M., Persky V., Scheff P., Wadden R., Ramaktirnan V., Hryhorczuk D.: Bioaerosol concentrations in the Quad Cities 1 year after the 1993 Mississippi River floods. Indoor Built Environ2000;9:35-43.
30.
Kuehn KA, Garrison R., Roberton L., Koehn RD, Johnson AL, Rea WJ: Identification of airborne micro-fungal population from home environments within the Dallas-Fort Worth (Texas) region. Indoor Environ1992; 1:285-292.
31.
TheInternational Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema. Lancet1998;351:1225-1232.
32.
NIOSH: Request for Assistance in Preventing Organic Dust Toxic Syndrome. Publ No 94-102. April 1994.
33.
Yunginger JW , Ahlstedt S., Eggleston PA, Homburger HA, Nelson HS, Ownby DR, Platts-Mills TA, Sampson HA, Sicherer SH, Weinstein AM, Williams PB, Wood RA, Zeiger RS: Quantitative IgE antibody assays in allergic diseases. J Allergy Clin Immunol2000; 105: 1077-1084.
34.
Williams PB , Barnes JH, Szeinbach SL, Sullivan TJ: Analytic precision and accuracy of commercial immunoassays for specific IgE: Establishing a standard . J Allergy Clin Immunol2000;105:1221-1230.
35.
Robertson LD : Monitoring viable fungal and bacterial bioaerosol concentrations to identify acceptable levels for common indoor environments . Indoor Built Environ1997;6:295-300.
36.
Stern MA, Allitt U., Corden J., Millington W.: The investigation of fungal spores in intramural air using a Burkard continuous recording air sampler. Indoor Built Environ1999;8:40-48.
37.
Brickus Lsr , Siqueira Lfg, de Aquino Neto FR, Cardoso JN: Occurrence of airborne bacteria and fungi on Bayside offices in Rio de Janeiro, Brazil. Indoor Built Environ1998 ;7:270-275.
38.
Bhattacharya K., Raha S., Majumdar MR: Measuring indoor fungal contaminants in rural West Bengal, India, with reference to allergy symptoms . Indoor Built Environ2001;10:40-48.
39.
Lacey J.: Indoor Aerobiology and Health in Building Mycology, Management of Health and Decay in Buildings. London, Spon , 1994, pp 77-130.
40.
Nahm D-H., Park H-S., Kim C-W., Park J-W., Hong C-S.: Seasonal variation of IgG subclass antibodies to house dust mite in sera from mite-sensitive asthmatic patients. Ann Allergy Asthma Immunol1998;80:411-415.
41.
Miller JD, Laflamme AM, Sobol Y., et al: Fungi and fungal products in some Canadian houses. IntBiodeterioration1998;24:103-120.
